Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

BLUECROSS BLUESHIELD OF TENNESSEE, INC.

UEI: W8Z5C4T7HNC6CAGE: 2P769

BLUECROSS BLUESHIELD OF TENNESSEE, INC. is a federal contractor, registered under UEI W8Z5C4T7HNC6 and CAGE code 2P769. It has been awarded $17,135,884,000 across 12 federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include Department Of Health And Human Services (hhs) and Tennessee Valley Authority.

Contact Information

Registration and classification details

Registration

UEI Code

W8Z5C4T7HNC6

CAGE Code

2P769

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

A8

NAICS Codes

524114Direct Health and Medical Insurance Carriers(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

BLUECROSS BLUESHIELD OF TENNESSEE, INC. operates as a health plan administrator within the federal government’s health services ecosystem, delivering managed care solutions and health benefit administration services. While specific award details are not available, their primary NAICS classification ...

BLUECROSS BLUESHIELD OF TENNESSEE, INC. operates as a health plan administrator within the federal government’s health services ecosystem, delivering managed care solutions and health benefit administration services. While specific award details are not available, their primary NAICS classification of 524114—Insurance Carriers, Direct Health and Medical Insurance—indicates a focus on underwriting, claims processing, provider network management, and member services for government-sponsored health programs. Their operational model likely includes utilization management, fraud detection, electronic health data exchange, and compliance with federal standards such as HIPAA and HITECH. Technical expertise centers on health information systems integration, population health analytics, and secure claims adjudication platforms supporting Medicare, Medicaid, and other public health initiatives. No agency relationships can be inferred from the provided data, as no contract awards or agency affiliations are listed. Consequently, there is no demonstrable pattern of engagement with federal departments or specific programmatic workstreams. The company’s industry focus is narrowly aligned with health insurance carrier operations, emphasizing risk pooling, benefit design, and administrative services for public health programs. Their market positioning is that of a regional health plan provider with capabilities in large-scale enrollment systems, provider payment models, and member-centric digital health platforms. As a 2L entity based in Chattanooga, Tennessee, BLUECROSS BLUESHIELD OF TENNESSEE, INC. is structured as a nonprofit health plan with a regional footprint. No government certifications are listed, and there is no indication of small business, HUBZone, or socioeconomic status designations. Their government market presence is inferred solely through their NAICS code, suggesting participation in federal health insurance contracting without publicly documented performance history.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Award Analytics & Distribution

Awards by Agency
Department Of Health And Human Services (hhs)$957.9M77.8%
Tennessee Valley Authority$274.2M22.3%
Awards by NAICS
Export
- Unknown NAICS$1.2B100%
Awards by Agency Over Time
Export
Awards by Place of Performance

Open opportunities in BLUECROSS BLUESHIELD OF TENNESSEE, INC.'s top NAICS codes and agencies

NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
This solicitation supports Small Business Technology Transfer (STTR) grants through the National Institutes of Health to fund research and development projects that advance innovative technologies with potential for commercialization, requiring a formal collaboration between a U.S.-owned small business and a nonprofit research institution. The award is made solely to the small business, regardless of where the principal investigator is employed, and projects must align with the missions of NIH, CDC, or FDA components. Funding is available for Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with Fast-Track allowing combined Phase I and II review to streamline the process. Direct to Phase II is an option for businesses that have already demonstrated technical merit without prior Phase I funding, provided the application is submitted as a new proposal, not a renewal. Only one Phase II award is permitted per Phase I project, and Phase IIB Strategic Breakthrough applications must go through a separate solicitation. Applications must focus on feasibility or R&D that supports public health goals and are subject to restrictions on clinical trials, which are not permitted under this NOFO if exclusively aligned with specific NIH institutes including NIAID, NIAMS, NIDCR, NIDDK, NIMHD, NCATS, and ORIP. The funding opportunity is part of the broader SBIR/STTR mandate, which requires NIH to set aside 0.45% of its extramural budget for STTR, ensuring support for small businesses with fewer than 500 employees. Applicants are encouraged to consult with program staff prior to submission to ensure alignment with funding priorities and to use the Assignment Request Form to suggest an appropriate awarding component, though such identification is not mandatory. The solicitation closes on August 5, 2026, and information on program details, priorities, and frequently asked questions is available through the NIH Seed Fund portal and related government strategies including the Make Our Children Healthy Again initiative.
Department of Health and Human Services

POSTED

3 months ago

DEADLINE

in 8 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
This funding opportunity supports U.S. small businesses in advancing early-stage research and development toward commercialization through the SBIR program, administered by the National Institutes of Health, Centers for Disease Control and Prevention, and Food and Drug Administration. Eligible small businesses must be U.S.-owned and operated with fewer than 500 employees and are expected to lead the majority of the technical effort, with the principal investigator primarily employed by the business. The program offers Phase I grants to establish technical feasibility, Phase II grants to advance development toward market readiness, and two special pathways: Direct to Phase II for projects with prior proof of concept but no prior Phase I award, and Fast-Track for combined Phase I and Phase II submissions reviewed concurrently to accelerate progress. All awards are granted to the small business, and commercialization must be pursued using non-SBIR funds after Phase II. The scientific scope must align with the missions of participating NIH, CDC, or FDA components, focusing on health improvement and public health innovation, with applicants encouraged to consult specific institute priorities and the White House’s Make Our Children Healthy Again Strategy. While clinical trials are permitted, they are explicitly excluded if the application aligns solely with certain NIH institutes or all FDA centers, making alignment critical for responsiveness. Applications must be submitted through the designated portal by the deadline, and while applicants are not required to specify an awarding component during submission, consultation with program staff beforehand is strongly advised to ensure proper alignment. The solicitation operates under a complete small business set-aside mandate and is open to new applications only, with no renewals accepted for Direct to Phase II submissions.
Department of Health and Human Services

POSTED

3 months ago

DEADLINE

in 8 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The Commercialization Readiness Pilot (CRP) program, issued under PAR-27-098, provides late-stage research and development funding and technical assistance to U.S. small business concerns that have previously received an NIH SBIR or STTR Phase II award or a Phase IIB Strategic Breakthrough award. This initiative is designed to bridge the gap between Phase II completion and full commercialization by supporting activities that require significant outsourcing, such as regulatory strategy, intellectual property development, manufacturing optimization, pre-clinical product development, and clinical trials—though not all NIH institutes accept clinical trial proposals. The program permits substantial outsourcing to contract research organizations but requires the small business to maintain active oversight and management of all scientific, financial, and administrative aspects of the work, with justified budget allocations reflecting this role. CRP funding cannot cover FDA filing fees or include separate Technical and Business Assistance (TABA) funds. Eligible applicants must be small business concerns under 500 employees meeting SBA size standards, and proposals must align with the mission of participating NIH components. The solicitation explicitly excludes applications that propose clinical trials solely aligned with certain NIH institutes, including NHLBI, NIAID, NIDDK, and others listed, which do not accept such trials under this program. Applications are limited to Type 1 new submissions, and prior Phase II funding is mandatory for eligibility. Applicants are strongly encouraged to consult with NIH program staff before submitting to ensure alignment with the most appropriate funding mechanism, as the Phase IIB Strategic Breakthrough program (PA-27-101) may be better suited for some projects with matching fund requirements. The solicitation is active through August 5, 2026, under a total small business set-aside, and further details are available through the NIH SBIR/STTR portal.
Department of Health and Human Services

POSTED

3 months ago

DEADLINE

in 8 months
View Details